На этой странице перечислены больницы направления «Бариатрическая хирургия» (включая Gastric Bypass Surgery) в Дубай, ОАЭ, включая Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai.
Спросите нас о «Gastric Bypass Surgery» в Дубай, ОАЭ
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 3 аккредитованных больниц (Бариатрическая хирургия) в Дубай, ОАЭ
Рекомендуем🇦🇪 Burjeel Hospital for Advanced Surgery Dubai
Больница занимает 1-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Kings College Hospital Dubai
Больница занимает 2-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Aster Hospital Dubai
Больница занимает 3-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Бариатрическая хирургия» указано среди её специализаций и она находится в Дубай, ОАЭ. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «gastric bypass surgery» в Дубай, ОАЭ?
Выбор подходящей больницы для «gastric bypass surgery» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Бариатрическая хирургия», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Gastric Bypass Surgery»
Gastric bypass surgery (Roux-en-Y gastric bypass) is a gold-standard bariatric procedure that restructures the digestive tract to achieve sustained weight loss of 60–80% of excess body weight, with clinical remission of Type 2 diabetes in up to 80% of patients and a long-term success rate exceeding 85%. International patients choose India and the UAE for this procedure because both destinations offer JCI-accredited centers staffed by fellowship-trained bariatric surgeons performing high-volume laparoscopic and robotic-assisted cases at a fraction of Western costs. GAF Healthcare coordinates every step of the medical journey — from pre-operative workup to post-operative follow-up — ensuring seamless, safe, and cost-effective care for patients traveling from Africa, the Middle East, Central Asia, and beyond. Hospital Stay: 3–5 days • Total Stay in Country (Fit-to-Fly): 3–4 weeks • Success Rate: 85–90%
Clinical Overview
Morbid obesity (BMI ≥ 35 with comorbidities, or BMI ≥ 40) is a chronic, multifactorial metabolic disease driven by dysregulation of adipokines, gut hormones (GLP-1, GIP, PYY), and hypothalamic appetite circuits. Excess adipose tissue generates a state of chronic low-grade inflammation, insulin resistance, dyslipidemia, obstructive sleep apnea, and hypertension, collectively increasing cardiovascular mortality risk by 50–100% compared to normal-weight individuals. Conservative measures — including structured low-calorie diets, GLP-1 receptor agonists (semaglutide, liraglutide), and behavioral therapy — achieve durable weight loss in fewer than 5% of morbidly obese patients at five-year follow-up, making surgical intervention the most evidence-based long-term solution. Gastric bypass surgery works through two synergistic mechanisms: restriction and malabsorption. The surgeon creates a small gastric pouch (15–30 mL) from the proximal stomach and connects it directly to the mid-jejunum via a Roux limb, bypassing the distal stomach, duodenum, and proximal jejunum. This anatomical rerouting dramatically reduces caloric absorption, suppresses ghrelin (the hunger hormone) by excluding the gastric fundus, and triggers a robust post-meal GLP-1 surge that improves insulin secretion and satiety. The result is progressive, sustained weight loss and metabolic improvement that no pharmacological agent alone can replicate. The current standard of care for Roux-en-Y gastric bypass (RYGB) is a laparoscopic or robotic-assisted minimally invasive approach, endorsed by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS). Accredited bariatric centers in India (NABH/JCI) and the UAE (JCI/DHA) follow multidisciplinary protocols that include mandatory pre-operative nutritional optimization, cardiac risk stratification using the Revised Cardiac Risk Index (RCRI), obstructive sleep apnea screening with polysomnography, and dedicated bariatric anesthesia teams skilled in managing patients with high BMI and difficult airways.
Who is a Candidate?
• BMI ≥ 40 kg/m² without comorbidities, OR BMI ≥ 35 kg/m² with at least one obesity-related comorbidity (Type 2 diabetes, hypertension, obstructive sleep apnea, NAFLD/NASH, osteoarthritis, GERD) • BMI ≥ 30–34.9 kg/m² with poorly controlled Type 2 diabetes or metabolic syndrome may qualify at selected centers under IFSO guidelines • Age 18–65 years (case-by-case evaluation for adolescents ≥ 16 with severe comorbidities or adults > 65) • Documented failure of at least 6 months of supervised non-surgical weight management • Psychological clearance confirming absence of active untreated eating disorders (binge eating disorder requires pre-operative CBT), severe uncontrolled psychiatric illness, or active substance use disorder • Motivation and ability to commit to lifelong nutritional supplementation (B12, iron, calcium with Vitamin D, folate) and post-operative follow-up Required Pre-Operative Diagnostics: • Complete metabolic panel: HbA1c, fasting insulin, HOMA-IR, lipid panel, thyroid function (TSH, Free T4) • Hematological workup: CBC, iron studies (serum ferritin, TIBC), Vitamin B12, Vitamin D (25-OH), folate • Cardiac assessment: 12-lead ECG; ECHO (2D echocardiogram) if BMI > 50, age > 45, or history of dyspnea/hypertension; stress test if indicated by RCRI ≥ 2 • Pulmonary: chest X-ray; formal polysomnography or WatchPAT home sleep study for OSA screening (STOP-BANG score ≥ 3) • Upper GI endoscopy (EGD) to rule out H. pylori, GERD, Barrett's esophagus, or gastric pathology that may alter surgical planning • Abdominal ultrasound to assess gallbladder (cholelithiasis is common in obese patients; concomitant cholecystectomy may be planned) • Nutritional counseling session and baseline DEXA scan (optional but recommended for lean mass vs. fat mass baseline) • Psychiatric/psychological evaluation (validated tools: Beck Depression Inventory, Binge Eating Scale) Contraindications: • Active malignancy undergoing treatment • Severe portal hypertension or cirrhosis (Child-Pugh B/C) • Uncontrolled severe psychiatric disorder (active psychosis, severe borderline personality disorder without specialist clearance) • Active substance abuse (alcohol, opioids) within 12 months • Pregnancy or planning pregnancy within 18 months post-surgery • Severe GERD with large hiatal hernia may favor sleeve gastrectomy over bypass in select cases (though RYGB also treats GERD — surgeon judgment required) • Inability to comply with lifelong nutritional follow-up
Treatment Options & Approaches
Gastric bypass surgery encompasses several technique variations and technological platforms. Understanding the differences helps patients and referring physicians select the most appropriate approach. 1. Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) — The Gold Standard The most commonly performed bariatric procedure globally. Using 5–6 small port incisions (5–12 mm), the surgeon creates a 15–30 mL proximal gastric pouch using a linear endoscopic stapler (e.g., Medtronic Signia or Ethicon Echelon series). The small bowel is divided approximately 30–50 cm from the ligament of Treitz; the Roux limb (typically 100–150 cm) is brought up to anastomose with the gastric pouch (gastrojejunostomy), while the biliopancreatic limb (50–75 cm) is joined distally (jejunojejunostomy). The anastomoses are fashioned using circular staplers (21–25 mm EEA) or linear staplers with hand-sewn oversewing. Intraoperative leak test is mandatory (methylene blue or endoscopic insufflation). Operative time: 90–150 minutes. This approach reduces hospital stay to 3–5 days and recovery time to 3–4 weeks versus 6–8 weeks for open surgery. 2. Robotic-Assisted Roux-en-Y Gastric Bypass (RRYGB) — Advanced Platform Performed using the da Vinci Xi or da Vinci SP surgical system (Intuitive Surgical), robotic assistance provides 3D high-definition magnified visualization, 7-degrees-of-freedom EndoWrist instrumentation, and tremor filtration. This platform is particularly advantageous for: (a) super-obese patients (BMI > 55) with increased abdominal wall thickness limiting laparoscopic triangulation; (b) revisional bariatric surgery (conversion from sleeve gastrectomy or failed adjustable gastric band); and (c) complex anastomotic fashioning in confined anatomical spaces. Robotic RYGB is associated with lower anastomotic leak rates (1.2% vs. 2.1% in laparoscopic series in high-volume centers) and reduced conversion to open surgery. Available at premium JCI-accredited centers in Mumbai, Chennai, Delhi (India) and Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai (UAE). 3. One-Anastomosis Gastric Bypass (OAGB) / Mini Gastric Bypass A simplified two-anastomosis-free technique (one gastrojejunostomy, no jejunojejunostomy) gaining IFSO recognition as an acceptable primary procedure. Faster operative time (60–90 min), comparable weight loss to LRYGB, but carries a theoretical risk of bile reflux gastritis. Suitable for patients prioritizing shorter operative time or with prior abdominal surgery limiting bowel mobilization. Less commonly offered for primary cases in high-volume Indian and UAE centers, where LRYGB remains preferred. 4. Revisional Bariatric Surgery Conversion of failed or complicated prior bariatric procedures (e.g., sleeve gastrectomy with weight regain, gastric band erosion or slippage) to RYGB. Technically demanding — robotic assistance is strongly preferred. Requires thorough pre-operative imaging (CT abdomen with oral contrast, upper GI series) and EGD. 5. Adjunctive Technologies & Protocols • Enhanced Recovery After Bariatric Surgery (ERABS) protocol: multimodal analgesia (TAP blocks, ketamine, IV acetaminophen), early ambulation (within 6 hours post-op), and same-day liquid diet initiation reduce hospital stay and opioid consumption. • Intraoperative endoscopy: simultaneous EGD during RYGB to assess anastomotic integrity. • ICG (Indocyanine Green) fluorescence imaging: used in robotic cases to assess anastomotic perfusion and reduce leak risk. • Continuous glucose monitoring (CGM) integration: post-operative glycemic management using CGM devices (e.g., Abbott FreeStyle Libre) for diabetic patients. • Pharmacological bridging: patients on GLP-1 receptor agonists (semaglutide/Ozempic) must discontinue 2 weeks pre-operatively to reduce aspiration risk from delayed gastric emptying.
Восстановление
Phase 1 — Pre-Operative Preparation (4–8 Weeks Before Surgery) • GAF Healthcare assigns a dedicated patient coordinator who collects all prior medical records, imaging, and labs for remote review by the treating bariatric surgeon. • Virtual consultation (video call) with the surgeon and bariatric dietitian to review candidacy, set weight-loss goals, and begin a 2–4 week pre-operative liver-shrinking diet (high-protein, low-carbohydrate, 800–1,200 kcal/day) to reduce liver volume by 15–20%, improving intraoperative visualization. • GLP-1 agonists (if prescribed) discontinued 2 weeks before surgery. Antidiabetic medications and anticoagulants adjusted per anesthesia protocol. • E-Medical visa application (India) or tourist/medical entry visa (UAE) facilitated by GAF Healthcare's visa team. • Pre-operative labs, ECG, ECHO, polysomnography, and EGD completed locally or on arrival at the partner hospital. Phase 2 — Arrival & Admission (2–3 Days Before Surgery) • GAF Healthcare airport pickup with dedicated coordinator. Transfer to partner hospital or pre-arranged accommodation. • Anesthesia pre-assessment clinic: airway assessment (Mallampati scoring, neck circumference), DVT risk stratification (Caprini score — most bariatric patients are high risk, requiring pharmacological prophylaxis with LMWH + sequential compression devices). • Surgeon marks operative site; consent obtained. Bowel prep not routinely required for RYGB. • Admission day: IV access, LMWH administered, compression stockings fitted. NPO (nil per os) from midnight. Phase 3 — Surgery Day • General anesthesia with rapid sequence induction (RSI) protocol due to high aspiration risk; video laryngoscopy (C-MAC or GlideScope) on standby for difficult airway. • Patient positioned in reverse Trendelenburg (20–30°) to optimize diaphragmatic excursion. • Laparoscopic or robotic ports placed; pneumoperitoneum established. • Gastric pouch creation → Roux limb measurement → gastrojejunostomy → jejunojejunostomy → intraoperative leak test → port closure. Duration: 90–150 minutes. • ICU/HDU observation for 12–24 hours post-operatively (standard for high-BMI patients; step down to ward if vitals and drain output stable). Phase 4 — In-Hospital Recovery (Days 1–5) • Day 1: Early ambulation (walking within 4–6 hours). Clear liquid diet commenced (30 mL/hour sips). Pain managed with IV acetaminophen + ketorolac ± low-dose opioid rescue. LMWH continued. • Day 2: Gastrografin swallow study or CT with oral contrast to confirm anastomotic integrity (protocol varies by center). Advance to full clear liquids. Respiratory physiotherapy (incentive spirometry). • Day 3–4: Advancement to pureed/protein shake diet. Oral medications resumed. Drain removal if output < 30 mL/24h and no bile staining. Bariatric dietitian review: protein target 60–80 g/day minimum. • Day 5: Discharge criteria met — tolerating liquids, ambulating independently, pain controlled on oral analgesics, no fever or tachycardia. Phase 5 — Post-Discharge Recovery (Weeks 1–4) • Weeks 1–2: Rest at GAF Healthcare-arranged accommodation near the hospital. Daily wound check by home-visit nurse or outpatient clinic. Diet progresses: clear liquids → full liquids → pureed → soft foods. • Week 2–3: Follow-up appointment with surgeon; suture/staple removal if non-absorbable. Blood work: CBC, metabolic panel, glucose. CPAP therapy continued if OSA documented. • Week 3–4: Patients cleared for air travel by the operating surgeon when: (a) no active wound complications, (b) tolerating soft diet without nausea/vomiting, (c) ambulating well (DVT risk substantially reduced), and (d) no fever or signs of anastomotic leak. Long-haul flights (> 6 hours) require continued LMWH prophylaxis on travel day. • Fitness to fly: typically 3–4 weeks post-operatively. Phase 6 — Long-Term Recovery & Follow-Up (Months 1–24) • Month 1: Soft to regular diet progression. Begin moderate exercise (walking 30 min/day). Continue all bariatric supplements. • Month 3: Significant weight loss milestone (20–30% EWL). Antidiabetic medications often dose-reduced or discontinued under physician guidance. • Month 6: 50–60% EWL typical. DEXA scan to assess lean mass preservation. Nutritional labs reviewed. • Month 12: 70–80% EWL. Skin redundancy assessment; body contouring consultation if desired. • Month 18–24: Weight stabilization. Long-term supplement adherence and annual lab monitoring required indefinitely. GAF Healthcare facilitates telemedicine follow-up with the operating surgical team for international patients.
Возможные риски
Gastric bypass surgery carries well-defined risks that are substantially mitigated by patient selection, high-volume surgical centers, and adherence to ERABS protocols. Patients must receive honest, complete informed consent before proceeding. Short-Term Surgical Risks (0–30 Days): • Anastomotic leak (most serious complication): 0.5–2.5% incidence in laparoscopic series at accredited centers; presents as tachycardia, fever, and abdominal pain on days 3–7. Managed with CT-guided drainage, endoscopic stenting (OTSC clips or covered metal stents), or surgical re-exploration. • Pulmonary embolism (PE) and deep vein thrombosis (DVT): 0.3–1.5%; mitigated by LMWH, early ambulation, and compression devices. Patients with prior PE or thrombophilia require extended anticoagulation. • Internal hemorrhage: 1–4%; may originate from staple lines or mesenteric vessels. Most resolve without re-intervention; 0.5% require surgical exploration. • Pulmonary complications: atelectasis, aspiration pneumonia — higher risk in patients with severe OSA (STOP-BANG ≥ 5) not compliant with pre-operative CPAP therapy. • Conversion to open surgery: < 1% at high-volume laparoscopic centers; higher for robotic-assisted revisional cases. Medium-Term Risks (1–12 Months): • Anastomotic stricture at gastrojejunostomy: 3–5%; presents as progressive dysphagia or vomiting; treated with endoscopic balloon dilation (usually 1–3 sessions with a 12–15 mm CRE balloon). • Marginal ulceration at the gastrojejunostomy: 1–16%; strongly associated with NSAIDs use, smoking, and H. pylori positivity. Treated with high-dose PPIs (pantoprazole 40 mg twice daily) and sucralfate. NSAID use is absolutely contraindicated post-RYGB. • Internal hernia (Petersen's defect, jejunojejunostomy mesenteric defect): 2–5%; presents with intermittent or acute severe abdominal pain; requires urgent CT and surgical exploration. Risk reduced by mesenteric defect closure during primary surgery. • Nutritional deficiencies: iron deficiency anemia (up to 50% of menstruating women without supplementation), Vitamin B12 deficiency, thiamine (Vitamin B1) deficiency (Wernicke's encephalopathy if severe), and Vitamin D/calcium deficiency leading to metabolic bone disease. Lifelong supplementation and annual blood monitoring are mandatory — not optional. • Dumping syndrome: early (30 min post-meal, osmotic — nausea, diarrhea, palpitations) and late (2–3 hours post-meal, hypoglycemic — diaphoresis, tremor). Managed with dietary modification (small frequent meals, avoidance of simple sugars). Long-Term Risks (> 1 Year): • Weight regain: 20–30% of patients regain > 50% of lost weight by 10 years without behavioral follow-up. Adjunctive GLP-1 agonist therapy (semaglutide post-RYGB) is an emerging evidence-based strategy for weight recidivism. • Gastroesophageal reflux disease (GERD): RYGB typically improves GERD, unlike sleeve gastrectomy. However, a small subset develops de novo biliary reflux into the esophagus. • Alcohol use disorder: altered alcohol metabolism post-RYGB (faster absorption, higher peak BAC) increases the risk of transfer addiction. Pre-operative counseling and post-operative monitoring are essential. • Hypoglycemia (post-bariatric hypoglycemic syndrome): rare but severe late dumping manifesting as neuroglycopenia; in refractory cases, managed with acarbose, diazoxide, or rarely partial pancreatectomy. Mortality Rate: 30-day mortality is 0.1–0.3% at accredited high-volume centers, comparable to laparoscopic cholecystectomy — making RYGB one of the safest major abdominal procedures when performed in the appropriate institutional setting.
Почему GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical support to ensure international patients experience a stress-free medical journey to India or the UAE. Visa & Documentation Assistance: • India: GAF Healthcare's documentation team assists patients in applying for the e-Medical Visa (e-MV) through India's official e-Visa portal. The e-MV is issued within 3–5 business days, allows a stay of up to 60 days (extendable), and permits entry through 30 designated airports. Patients receive a hospital invitation letter (required for the e-MV application) directly from GAF Healthcare's partner hospital. • UAE (Dubai/Abu Dhabi): Citizens of 50+ countries (including most of the EU, UK, USA, Australia, and GCC nationals) receive a 30–90 day visa on arrival or visa-free access. Patients from countries requiring prior visas (including many African nations) receive full visa application guidance and hospital support letters. Medical tourism visas for the UAE are valid for up to 90 days and can be sponsored by DHA-licensed facilities. Airport Transfers: • Dedicated GAF Healthcare coordinators or vetted ground transport partners meet patients (and attendants) at the arrival terminal with name placards. • Vehicles are bariatric-ready where required (wide-door SUVs, no narrow sedans) with clean, air-conditioned comfort. • Transfer on discharge from hospital to accommodation, and on departure day back to the airport, is fully coordinated. Accommodation: • GAF Healthcare pre-negotiates discounted rates at partner serviced apartments and hotels within 5–15 minutes of each partner hospital, accommodating the patient and one to two attendants (family members/caregivers). • Rooms include kitchenette facilities for preparing the post-bariatric liquid and pureed diet phases at home, rather than relying on room service. • For India, options range from budget-friendly guesthouses (USD 25–50/night) to premium serviced apartments (USD 80–150/night). For the UAE, partner accommodations range from 3-star hotels (USD 80–130/night) to 5-star medical hotel suites (USD 250–500/night). Dedicated Translator & Cultural Support: • GAF Healthcare provides Arabic, French, Swahili, Russian, and Bangla interpreters (on-site or via certified medical interpretation video link) at partner hospitals in India. • In the UAE, most clinical staff at JCI-accredited hospitals are multilingual (Arabic, English, Hindi/Urdu, Filipino). GAF Healthcare supplements this with patient coordinators fluent in the patient's preferred language. Post-Discharge & Telemedicine Follow-Up: • GAF Healthcare's post-care team schedules telemedicine video consultations with the operating bariatric surgeon at 2 weeks, 6 weeks, 3 months, and 6 months post-surgery. • Lab reports from the patient's home country are remotely reviewed and nutritional supplement adjustments made accordingly. • 24/7 emergency helpline staffed by GAF Healthcare medical coordinators is provided to all active patients during their in-country stay. Insurance & Financial Coordination: • GAF Healthcare provides itemized cost estimates and official hospital quotations, which patients can submit to their insurance providers for reimbursement claims. • For self-pay patients, flexible payment scheduling (deposit + balance on admission) is arranged with partner hospitals.
Частые вопросы о процедуре «Gastric Bypass Surgery»
What is the cost of gastric bypass surgery in India vs. the UAE?
How long do I need to stay in the country before I am fit to fly home after gastric bypass surgery?
What is the success rate of gastric bypass surgery?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «gastric bypass surgery» в Дубай, ОАЭ
Найдите лучшие больницы для «gastric bypass surgery» в Дубай, ОАЭ
На этой странице представлено 3 больниц в Дубай, ОАЭ, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Gastric Bypass Surgery» в Дубай, ОАЭ
Сколько больниц направления «Бариатрическая хирургия» представлено в Дубай, ОАЭ?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Дубай, ОАЭ?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Gastric Bypass Surgery» в Дубай, ОАЭ.
Свяжитесь с нами, если заметите неточность на этой странице.